Exclusively focused on representing plaintiffs, especially in mass tort litigation, Eric Chaffin prides himself on providing unsurpassed professional legal services in pursuit of the specific goals of his clients and their families.
In January 2014, the FDA released a drug safety communication announcing they were investigating the risk of serious side effects—including stroke, heart attack, and death—in men taking testosterone replacement products. They released the warning in response to a couple of major studies that had ind
In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into one court in the Eastern District of Louisiana before the Honorable Judge Fallon. Currently, about 400 cases are pending there. One of the cases recently filed involves a…
Over the past few years, health experts have been questioning the effectiveness of testosterone replacement drugs for helping men to improve their sexual function and quality of life. Though products like Androderm and AndroGel have become very popular, some studies have linked them with a…
On May 15, 2015, the Food and Drug Administration (FDA) released a drug safety communication warning doctors and patients about serious side effects associated with type 2 diabetes medication Invokana (canagliflozen), and other similar medications. Since that warning, Invokana attorneys have been in
In May 2015, the FDA warned that type 2 diabetes drugs like Invokana could have a potentially dangerous side effect: diabetic ketoacidosis (DKA). This is a serious condition in which the blood becomes too acidic, and can lead to complications like dehydration, coma, and even…
We’ve all seen direct-to-consumer advertisements for medications. They usually show people improving over a short period of time, and experiencing a much more vibrant and exciting life after taking the company’s drug. Though the side effects are usually listed, the overall messages in these advertis
The number of Zofran lawsuits filed in courts around the country continues to increase. Parents claim that Zofran manufacturers GlaxoSmithKline (GSK) failed to provide adequate warnings about the risks of birth defects when the medication is taken by pregnant women. Considering the rising litigation
Federal Xarelto lawsuits were consolidated into the Eastern District of Louisiana in December 2014. Since then, the number of Xarelto lawsuits filed has continued to increase. In the first week of August 2015, nearly 200 cases joined the MDL bundled together as four different lawsuits.…
Progress is being made in the testosterone MDL proceedings taking place in the Northern District of Illinois. There are nearly 2,000 testosterone lawsuits pending there, filed by plaintiffs who claim to have taken testosterone replacement drugs and then suffered from serious side effects like heart…
Last May (2015), the FDA warned healthcare professionals and type 2 diabetes patients that so-called SGLT2 inhibitors, like Invokana, could potentially increase risk of diabetic ketoacidosis, a dangerous condition that can lead to dehydration, coma, and even death. Among those who weren’t surprised:
It’s not only women who experience changes as they get older. Men, too, can suffer from reduced libido, muscle loss, increased weight, and dropping energy levels. Though these are typical symptoms of aging, several testosterone-replacement drug manufacturers used marketing materials and advertisemen
A number of women have blamed the anti-nausea drug Zofran (ondansetron) for causing their children’s birth defects. Had they known that the drug could increase risk of such defects, many say, they never would have taken it. Unfortunately, Zofran manufacturers GlaxoSmithKline (GSK) conducted a large…
